Skip to main content


Fig. 2 | Nutrition & Metabolism

Fig. 2

From: The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity

Fig. 2

Fecal lipopolysaccharide (LPS) (a), intestinal expression of toll-like receptor 4 (TLR4) (b), plasma monocyte chemoattractant protein-1 (MCP-1) (c) and serum interleukin-1 beta (IL-1β) (d) of Wistar rats fed either with standard (St) or high-fat (HF) diet during 12 weeks. Data are presented as mean ± SEM (n = 3–6 rats per group). * P < 0.05 vs respective St diet group

Back to article page